Literature DB >> 10460584

Time trends in incidence of haematological malignancies and related conditions.

R A Cartwright1, E A Gilman, K A Gurney.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10460584     DOI： 10.1046/j.1365-2141.1999.01480.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Alain Monnereau; Susan L Slager; Ann Maree Hughes; Alex Smith; Bengt Glimelius; Thomas M Habermann; Sonja I Berndt; Anthony Staines; Aaron D Norman; James R Cerhan; Joshua N Sampson; Lindsay M Morton; Jacqueline Clavel
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

3.  Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan.

Authors:  Jia-Hong Chen; Chi-Hsiang Chung; Yung-Chih Wang; Shun-Neng Hsu; Wen-Yen Huang; Wu-Chien Chien
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

4.  A national study of the unmet needs of support persons of haematological cancer survivors in rural and urban areas of Australia.

Authors:  Marita C Lynagh; A Williamson; K Bradstock; S Campbell; M Carey; C Paul; F Tzelepis; R Sanson-Fisher
Journal:  Support Care Cancer       Date:  2018-01-08       Impact factor: 3.603

5.  Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysis.

Authors:  Wei-Nung Liu; Chao-Feng Chang; Chi-Hsiang Chung; Wu-Chien Chien; Tzu-Chuan Huang; Yi-Ying Wu; Ching-Liang Ho; Jia-Hong Chen
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.